Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
miércoles, octubre 21
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Fortrea Holdings Inc
FTRE
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$22.78
0.36
1.61%
Últ. Act.: Oct 20, 4:56 PM
$22.78
0.36
1.61%
Get Report
Panorámica general
Noticias
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Propiedad
Comparar
Opciones
Informe de acciones
Privacy Manager
Ganancias:
Beneficios de Q3 2026 dentro de 8 días de ahora en jue oct 29th, antes de la apertura del mercado
Fusiones y adquisiciones:
Worldwide Clinical Trials sold assets to Fortrea Holdings (FTRE) on Monday, October 19, 2026 for $45M
Fortrea Holdings Financials
Fortrea Holdings (FTRE) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Fortrea Holdings Q2 Adj. EPS $0.23 Beats $0.18 Estimate, Sales $678.200M Beat $647.465M Estimate
Fortrea Holdings (NASDAQ:FTRE) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate of $0.18 by 27.78 percent. This is a 21.05 percent increase over earnings of $0.19 per share from
Benzinga Newsdesk
PRO
Fortrea Holdings Raises FY2026 Sales Guidance from $2.550B-$2.650B to $2.620B-$2.690B vs $2.607B Est
Fortrea Holdings (NASDAQ:FTRE) raises FY2026 sales outlook from $2.550 billion-$2.650 billion to $2.620 billion-$2.690 billion vs $2.607 billion estimate.
Benzinga Newsdesk
Fortrea Reiterates FY26 Guidance, Targeting Revenues In Range Of $2.550B-$2.650B Vs $2.594B Est., And Adjusted EBITDA Of $190M-$220M
2026 Financial GuidanceThe Company reiterates its guidance for the full year 2026, targeting revenues in the range of $2,550 million to $2,650 million and adjusted EBITDA in the range of $190 million to $220 million.
Benzinga News-desk
Earnings Scheduled For May 5, 2026
Benzinga Insights
PRO
Fortrea Holdings Affirms FY2026 Sales Guidance of $2.550B-$2.650B vs $2.594B Est
Fortrea Holdings (NASDAQ:FTRE) affirms FY2026 sales outlook from $2.550 billion-$2.650 billion to $2.550 billion-$2.650 billion vs $2.594 billion estimate.
Benzinga Newsdesk
PRO
Fortrea Holdings Q1 Adj. EPS $0.16 Beats $0.05 Estimate, Sales $636.500M Beat $625.397M Estimate
Fortrea Holdings (NASDAQ:FTRE) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.05 by 220 percent. This is a 700 percent increase over earnings of $0.02 per share from the
Benzinga Newsdesk
